Inhibition of P-fimbriated Escherichia coli adhesion by multivalent galabiose derivatives studied by a live-bacteria application of surface plasmon resonance.

OBJECTIVES Uropathogenic P-fimbriated Escherichia coli adheres to host cells by specific adhesins recognizing galabiose (Galalpha1-4Gal)-containing structures on cell surfaces. In search of agents inhibiting this first step of infection, the inhibition potency of a set of synthetic mono- and multivalent galabiose compounds was evaluated. In order to mimic the flow conditions of natural infections, a live-bacteria application of surface plasmon resonance (SPR) was established. METHODS AND RESULTS For the measurement of the binding of E. coli to a surface containing galabiose, live bacteria were injected over the flow cell, and the inhibition of adhesion caused by the galabiose inhibitors was recorded. Quantitative binding data were recorded in real-time for each inhibitor. The results were compared with those of conventional static haemagglutination and ELISA-based cell adhesion assays. Compared with the Gram-positive Streptococcus suis bacteria, which also bind to galabiose and whose binding inhibition is strongly dependent on the multivalency of the inhibitor, E. coli inhibition was only moderately affected by the valency. However, a novel octavalent compound was found to be the most effective inhibitor of E. coli PapG(J96) adhesion, with an IC50 value of 2 microM. CONCLUSIONS Measurement of bacterial adhesion by SPR is an efficient way to characterize the adhesion of whole bacterial cells and allows the characterization of the inhibitory potency of adhesion inhibitors under dynamic flow conditions. Under these conditions, multivalency increases the anti-adhesion potency of galabiose-based inhibitors of P-fimbriated E. coli adhesion and provides a promising approach for the design of high-affinity anti-adhesion agents.

[1]  Roland J. Pieters.  Intervention with Bacterial Adhesion by Multivalent Carbohydrates , 2008 .

[2]  S. Normark,et al.  Host‐specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1‐4Gal‐containing isoreceptors. , 1990, The EMBO journal.

[3]  H. Goldfine,et al.  Porcine 987P glycolipid receptors on intestinal brush borders and their cognate bacterial ligands , 1996, Infection and immunity.

[4]  J. Hacker,et al.  Receptor Structure for F1C Fimbriae of Uropathogenic Escherichia coli , 2000, Infection and Immunity.

[5]  S. Nishimura,et al.  Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands , 2002, Chembiochem : a European journal of chemical biology.

[6]  S. Hultgren,et al.  PapG adhesin from E. coli J96 recognizes the same saccharide epitope when present on whole bacteria and as isolated protein. , 1996, Bioorganic & medicinal chemistry.

[7]  M. Chengappa,et al.  Streptococcus Suis: Past and Present , 1997, Veterinary Research Communications.

[8]  S. Normark,et al.  Saccharide orientation at the cell surface affects glycolipid receptor function. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Normark,et al.  Genes of pyelonephritogenic E. coli required for digalactoside‐specific agglutination of human cells. , 1984, The EMBO journal.

[10]  E. Beachey,et al.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. , 1981, The Journal of infectious diseases.

[11]  G. Magnusson,et al.  Determination of the cell adhesion specificity of Streptococcus suis with the complete set of monodeoxy analogues of globotriose , 2004, Glycoconjugate Journal.

[12]  E. Dawes,et al.  Enterobacterial surface antigens : methods for molecular characterisation , 1985 .

[13]  Stephen D Holmes,et al.  Studies on the interaction of staphylococcus aureus and staphylococcus epidermidis with fibronectin using surface plasmon resonance (BIAcore) , 1997 .

[14]  Thisbe K Lindhorst,et al.  Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary α-mannosyl clusters: The effect of multivalency , 1998, Glycoconjugate Journal.

[15]  J. Hacker,et al.  Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli , 2005 .

[16]  C. V. D. Hondel,et al.  Studies on the fimbriae of an Escherichia coli O6:K2:H1:F7 strain: Molecular cloning of a DNA fragment encoding a fimbrial antigen responsible for mannose-resistant hemagglutination of human erythrocytes , 1983 .

[17]  C. Schengrund.  "Multivalent" saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. , 2003, Biochemical pharmacology.

[18]  D. Zopf,et al.  Oligosaccharide anti-infective agents , 1996, The Lancet.

[19]  J. Huskens.  Multivalent interactions at interfaces. , 2006, Current opinion in chemical biology.

[20]  S. Normark,et al.  Uropathogenic, Escherichia coli can express serologically identical pili of different receptor binding specificities , 1988, Molecular microbiology.

[21]  K. Karlsson,et al.  Oligosaccharide-receptor interaction of the Gal alpha 1-4Gal binding adhesin of Streptococcus suis. Combining site architecture and characterization of two variant adhesin specificities. , 1994, The Journal of biological chemistry.

[22]  A. Lundblad,et al.  The Pk Antigen as Receptor for the Haemagglutinin of Pyelonephritic Escherichia coli , 1980 .

[23]  G. Magnusson,et al.  Di-, Tri-, and Tetravalent Dendritic Galabiosides That Inhibit Hemagglutination by Streptococcus suis at Nanomolar Concentration , 1997 .

[24]  Sten Ohlson,et al.  Binding interactions of Escherichia coli with globotetraosylceramide (globoside) using a surface plasmon resonance biosensor. , 2004, Journal of microbiological methods.

[25]  R. Liskamp,et al.  Inhibition of Streptococcus suis adhesion by dendritic galabiose compounds at low nanomolar concentration. , 2004, Journal of medicinal chemistry.

[26]  S. Hultgren,et al.  Probing of the combining site of the PapG adhesin of uropathogenic Escherichia coli bacteria by synthetic analogs of galabiose , 1989 .

[27]  Walter Huber,et al.  Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology. , 2006, Current pharmaceutical design.

[28]  R. Autar,et al.  Adhesion Inhibition of F1C‐Fimbriated Escherichia coli and Pseudomonas aeruginosa PAK and PAO by Multivalent Carbohydrate Ligands , 2003, Chembiochem : a European journal of chemical biology.

[29]  Priyabrata Pattnaik,et al.  Surface plasmon resonance , 2005, Applied biochemistry and biotechnology.

[30]  B. Finlay,et al.  Exploitation of mammalian host cell functions by bacterial pathogens. , 1997, Science.

[31]  S. Haataja,et al.  Hemagglutination activities of group B, C, D, and G streptococci: demonstration of novel sugar-specific cell-binding activities in Streptococcus suis , 1989, Infection and immunity.

[32]  Viola Vogel,et al.  Bacterial Adhesion to Target Cells Enhanced by Shear Force , 2002, Cell.

[33]  S. Haataja,et al.  Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides. , 1993, The Journal of biological chemistry.

[34]  Nathan Sharon,et al.  Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.

[35]  S. Hultgren,et al.  Structural requirements for the glycolipid receptor of human uropathogenic Escherichia coli , 1995, Molecular microbiology.